AKAR, E. E. Et Al. 2013. Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2 , 136-140.

AKAR, E. E., Oner, V., Kucukerdonmez, C., & AKOVA, Y. A., (2013). Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, 136-140.

AKAR, Ebru Et Al. "Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model," INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, 136-140, 2013

AKAR, Ebru E. Et Al. "Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model." INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, pp.136-140, 2013

AKAR, E. E. Et Al. (2013) . "Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model." INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , vol.6, no.2, pp.136-140.

@article{article, author={Ebru Eren AKAR Et Al. }, title={Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model}, journal={INTERNATIONAL JOURNAL OF OPHTHALMOLOGY}, year=2013, pages={136-140} }